Clinical trial
Isolated Hepatic Perfusion With Melphalan in Treating Patients With Unresectable…
NCT00089401 · National Institutes of Health Clinical Center (CC), NIH · Completed
Key facts
| NCT number | NCT00089401 |
|---|---|
| Title | Isolated Hepatic Perfusion With Melphalan in Treating Patients With Unresectable Colorectal Cancer That Has Metastasized to the Liver |
| Official title | A Phase II Trial Of Isolated Hepatic Perfusion (IHP) With Melphalan For Subjects With Metastatic Unresectable Colorectal Cancers Of The Liver With Disease Refractory To First Line Systemic Chemotherapy |
| Lead sponsor | National Institutes of Health Clinical Center (CC), NIH |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer, Metastatic Cancer |
| Intervention type | Drug, Procedure |
| Interventions | isolated perfusion, melphalan, conventional surgery |
| Enrollment | 8 |
| Start date | Jul 1, 2004 |
| Primary completion | Nov 1, 2006 |
| Completion | Mar 1, 2008 |
| First posted | Aug 5, 2004 |
| Last update posted | May 14, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: